1: Siddique YH, Naz F, Rahul, Varshney H. Comparative study of rivastigmine and
galantamine on the transgenic <i>Drosophila</i> model of Alzheimer's disease.
Curr Res Pharmacol Drug Discov. 2022 Jul 31;3:100120. doi:
10.1016/j.crphar.2022.100120. PMID: 35992376; PMCID: PMC9389239.

2: Gupta DS, Bagwe Parab S, Kaur G. Promising effects of emoxypine and its
succinate derivative in the management of various diseases-with insights on
recent patent applications. Curr Res Pharmacol Drug Discov. 2022 Aug 1;3:100121.
doi: 10.1016/j.crphar.2022.100121. PMID: 35992374; PMCID: PMC9389226.

3: Iwatsubo T. Molecular Pathogenesis and Disease-modifying Therapies of
Alzheimer's Disease and Related Disorders. JMA J. 2022 Jul 15;5(3):307-313. doi:
10.31662/jmaj.2022-0079. Epub 2022 Jun 17. PMID: 35992282; PMCID: PMC9358130.

4: Turk KW, Vives-Rodriguez A, Schiloski KA, Marin A, Wang R, Singh P, Hajos GP,
Powsner R, DeCaro R, Budson AE. Amyloid PET ordering practices in a memory
disorders clinic. Alzheimers Dement (N Y). 2022 Aug 17;8(1):e12333. doi:
10.1002/trc2.12333. PMID: 35992217; PMCID: PMC9382692.

5: Vives-Rodriguez AL, Schiloski KA, Marin A, Wang R, Hajos GP, Powsner R,
DeCaro R, Budson AE, Turk KW. Impact of amyloid PET in the clinical care of
veterans in a tertiary memory disorders clinic. Alzheimers Dement (N Y). 2022
Aug 17;8(1):e12320. doi: 10.1002/trc2.12320. PMID: 35992216; PMCID: PMC9382691.

6: Kent BA, Casciola AA, Carlucci SK, Chen M, Stager S, Mirian MS, Slack P,
Valerio J, McKeown MJ, Feldman HH, Nygaard HB. Home EEG sleep assessment shows
reduced slow-wave sleep in mild-moderate Alzheimer's disease. Alzheimers Dement
(N Y). 2022 Aug 16;8(1):e12347. doi: 10.1002/trc2.12347. PMID: 35992215; PMCID:
PMC9381912.

7: Tsumagari K, Sato Y, Shimozawa A, Aoyagi H, Okano H, Kuromitsu J. Co-
expression network analysis of human tau-transgenic mice reveals protein modules
associated with tau-induced pathologies. iScience. 2022 Aug 5;25(8):104832. doi:
10.1016/j.isci.2022.104832. PMID: 35992067; PMCID: PMC9382322.

8: Jin CY, Yu SW, Yin JT, Yuan XY, Wang XG. Corresponding risk factors between
cognitive impairment and type 1 diabetes mellitus: A narrative review. Heliyon.
2022 Aug 3;8(8):e10073. doi: 10.1016/j.heliyon.2022.e10073. PMID: 35991978;
PMCID: PMC9389196.

9: Ren W, Li L, Zhang J, Vaas M, Klohs J, Ripoll J, Wolf M, Ni R, Rudin M. Non-
invasive visualization of amyloid-beta deposits in Alzheimer amyloidosis mice
using magnetic resonance imaging and fluorescence molecular tomography. Biomed
Opt Express. 2022 Jun 8;13(7):3809-3822. doi: 10.1364/BOE.458290. PMID:
35991935; PMCID: PMC9352276.

10: Wang F, Chen H, Hu Y, Chen L, Liu Y. Integrated comparative metabolomics and
network pharmacology approach to uncover the key active ingredients of
<i>Polygonati rhizoma</i> and their therapeutic potential for the treatment of
Alzheimer's disease. Front Pharmacol. 2022 Aug 4;13:934947. doi:
10.3389/fphar.2022.934947. PMID: 35991900; PMCID: PMC9385993.

11: Shahbaz K, Chang D, Zhou X, Low M, Seto SW, Li CG. Crocins for Ischemic
Stroke: A Review of Current Evidence. Front Pharmacol. 2022 Aug 5;13:825842.
doi: 10.3389/fphar.2022.825842. PMID: 35991882; PMCID: PMC9388830.

12: Wang H, Dai JY, He YZ, Xia ZW, Chen XF, Hong ZY, Chai YF. Therapeutic effect
and mechanism of <i>Anemarrhenae Rhizoma</i> on Alzheimer's disease based on
multi-platform metabolomics analyses. Front Pharmacol. 2022 Aug 4;13:940555.
doi: 10.3389/fphar.2022.940555. PMID: 35991874; PMCID: PMC9385998.

13: Wang B, Caffo BS, Luo X, Liu CF, Faria AV, Miller MI, Zhao Y; Alzheimer’s
Disease Neuroimaging Initiative‡. Regularized regression on compositional trees
with application to MRI analysis. J R Stat Soc Ser C Appl Stat. 2022
Jun;71(3):541-561. doi: 10.1111/rssc.12545. Epub 2022 Mar 17. PMID: 35991528;
PMCID: PMC9387759.

14: Peng S, Li F, Yu K, Zhou F, Yu H, Liu H, Guo J, Li G, Wang C, Yan X, Li Z.
Integrating transcriptome and chemical analyses to reveal the anti-Alzheimer's
disease components in <i>Verbena officinalis</i> Linn. Front Plant Sci. 2022 Aug
4;13:955075. doi: 10.3389/fpls.2022.955075. PMID: 35991454; PMCID: PMC9386363.

15: Yang C, Qin S, Zhang J, Wang Y, Li H, Lü T. Sulforaphane Upregulates
Cultured Mouse Astrocytic Aquaporin-4 Expression through p38 MAPK Pathway. J
Healthc Eng. 2022 Aug 10;2022:1144124. doi: 10.1155/2022/1144124. PMID:
35991296; PMCID: PMC9385362.

16: Nordengen K, Pålhaugen L, Bettella F, Bahrami S, Selnes P, Jarholm J,
Athanasiu L, Shadrin A, Andreassen OA, Fladby T. Phenotype-informed polygenic
risk scores are associated with worse outcome in individuals at risk of
Alzheimer's disease. Alzheimers Dement (Amst). 2022 Aug 15;14(1):e12350. doi:
10.1002/dad2.12350. PMID: 35991219; PMCID: PMC9376972.

17: den Haan J, Hart de Ruyter FJ, Lochocki B, Kroon MAGM, Kemper EM, Teunissen
CE, van Berckel B, Scheltens P, Hoozemans JJ, van de Kreeke A, Verbraak FD, de
Boer JF, Bouwman FH. No difference in retinal fluorescence after oral curcumin
intake in amyloid-proven AD cases compared to controls. Alzheimers Dement
(Amst). 2022 Aug 15;14(1):e12347. doi: 10.1002/dad2.12347. PMID: 35991218;
PMCID: PMC9376971.

18: Chéour S, Chéour C, Kilani C, Guemri A, Zineddine D, Khélifa R, Supriya R,
Bragazzi NL, Chéour F, Baker JS, Gaied-Chortane S. Salivary Testosterone and
Cortisol Levels in Tunisian Elderly Male Patients With Mild Alzheimer's Disease.
Implications of Musical Therapy And/Or Physical Rehabilitation. Front Physiol.
2022 Aug 5;13:839099. doi: 10.3389/fphys.2022.839099. PMID: 35991172; PMCID:
PMC9389036.

19: Wang Z, Feng Y, Wang Y, Qiu H, Rui Z, Li M, Lv L. Meta-Analysis of the
Efficacy and Safety of Olanzapine versus Clozapine when Treating Senile
Dementia. Comput Math Methods Med. 2022 Aug 11;2022:5046761. doi:
10.1155/2022/5046761. PMID: 35991140; PMCID: PMC9388268.

20: Movahed RA, Rezaeian M. Automatic Diagnosis of Mild Cognitive Impairment
Based on Spectral, Functional Connectivity, and Nonlinear EEG-Based Features.
Comput Math Methods Med. 2022 Aug 11;2022:2014001. doi: 10.1155/2022/2014001.
PMID: 35991131; PMCID: PMC9388263.

21: Zhang F, Ran Y, Tahir M, Li Z, Wang J, Chen X. Regulation of
N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and
ischemic stroke. Front Cell Neurosci. 2022 Aug 4;16:955222. doi:
10.3389/fncel.2022.955222. PMID: 35990887; PMCID: PMC9386152.

22: Martins AC, Virgolini MB, Tinkov AA, Skalny AV, Tirumala RP, Farina M,
Santamaria A, Lu R, Aschner M. Iron overload and neurodegenerative diseases:
What can we learn from <i>Caenorhabditis elegans</i>? Toxicol Res Appl. 2022
Jan-Dec;6:10.1177/23978473221091852. doi: 10.1177/23978473221091852. Epub 2022
Apr 23. PMID: 35990536; PMCID: PMC9390093.

23: Alghamedy FH, Shafiq M, Liu L, Yasin A, Khan RA, Mohammed HS. Machine
Learning-Based Multimodel Computing for Medical Imaging for Classification and
Detection of Alzheimer Disease. Comput Intell Neurosci. 2022 Aug
12;2022:9211477. doi: 10.1155/2022/9211477. PMID: 35990121; PMCID: PMC9391119.

24: Liang L, Yan J, Huang X, Zou C, Chen L, Li R, Xie J, Pan M, Zou D, Liu Y.
Identification of molecular signatures associated with sleep disorder and
Alzheimer's disease. Front Psychiatry. 2022 Aug 4;13:925012. doi:
10.3389/fpsyt.2022.925012. PMID: 35990086; PMCID: PMC9386361.

25: Moore RC, Ackerman RA, Russell MT, Campbell LM, Depp CA, Harvey PD, Pinkham
AE. Feasibility and validity of ecological momentary cognitive testing among
older adults with mild cognitive impairment. Front Digit Health. 2022 Aug
5;4:946685. doi: 10.3389/fdgth.2022.946685. PMID: 35990012; PMCID: PMC9390883.

26: Wu Z, Woods RL, Chong TT, Orchard SG, McNeil JJ, Shah RC, Wolfe R, Murray
AM, Storey E, Ryan J. Potential modifiable factors associated with late-life
cognitive trajectories. Front Neurol. 2022 Aug 3;13:950644. doi:
10.3389/fneur.2022.950644. PMID: 35989918; PMCID: PMC9381981.

27: Hoyo V, Shah RC, Dave G, Volkov BB. Integrating special and underserved
populations in translational research: Environmental scan of adaptive capacity
and preparedness of Clinical and Translational Science Award (CTSA) program
hubs. J Clin Transl Sci. 2022 Jun 7;6(1):e89. doi: 10.1017/cts.2022.414. PMID:
35989859; PMCID: PMC9379934.

28: Taipala E, Pfitzer JC, Hellums M, Reed MN, Gramlich MW.
rTg(Tau<sub>P301L</sub>)4510 mice exhibit increased VGlut1 in hippocampal
presynaptic glutamatergic vesicles and increased extracellular glutamate
release. Front Synaptic Neurosci. 2022 Aug 3;14:925546. doi:
10.3389/fnsyn.2022.925546. PMID: 35989711; PMCID: PMC9383415.

29: Anyachor CP, Dooka DB, Orish CN, Amadi CN, Bocca B, Ruggieri F, Senofonte M,
Frazzoli C, Orisakwe OE. Mechanistic considerations and biomarkers level in
nickel-induced neurodegenerative diseases: An updated systematic review. IBRO
Neurosci Rep. 2022 Jul 31;13:136-146. doi: 10.1016/j.ibneur.2022.07.005. PMID:
35989698; PMCID: PMC9382260.

30: Pressman PS, Chen KH, Casey J, Sillau S, Chial HJ, Filley CM, Miller BL,
Levenson RW. Incongruences Between Facial Expression and Self-Reported Emotional
Reactivity in Frontotemporal Dementia and Related Disorders. J Neuropsychiatry
Clin Neurosci. 2022 Aug 22:appineuropsych21070186. doi:
10.1176/appi.neuropsych.21070186. Epub ahead of print. PMID: 35989572.

31: Gupta A, Montgomery RN, Young K, Mukherjee R, Chakraborty S, Thomas TS,
Cibrik DM, Drew D, Sarnak M. Pre-transplant cognitive screening is a poor
predictor of post-transplant cognitive status. Clin Transplant. 2022 Aug
21:e14798. doi: 10.1111/ctr.14798. Epub ahead of print. PMID: 35989467.

32: Sartor-Pfeiffer J, Lingel M, Stefanou MI, Lindig T, Bender B, Poli S,
Ziemann U, Fritsche A, Feil K, Mengel A. Regional computed tomography perfusion
deficits in patients with hypoglycemia: two case reports. Neurol Res Pract. 2022
Aug 22;4(1):36. doi: 10.1186/s42466-022-00201-z. PMID: 35989342; PMCID:
PMC9394021.

33: Thorp JG, Mitchell BL, Gerring ZF, Ong JS, Gharahkhani P, Derks EM, Lupton
MK. Genetic evidence that the causal association of educational attainment with
reduced risk of Alzheimer's disease is driven by intelligence. Neurobiol Aging.
2022 Nov;119:127-135. doi: 10.1016/j.neurobiolaging.2022.07.011. Epub 2022 Jul
30. PMID: 35989212.

34: Yousefizadeh A, Piccioni G, Saidi A, Triaca V, Mango D, Nisticò R.
Pharmacological targeting of microglia dynamics in Alzheimer's disease:
Preclinical and clinical evidence. Pharmacol Res. 2022 Aug 18;184:106404. doi:
10.1016/j.phrs.2022.106404. Epub ahead of print. PMID: 35988869.

35: Liu Y, Xin H, Zhang Y, Che F, Shen N, Cui Y. Leaves, seeds and exocarp of
Ginkgo biloba L. (Ginkgoaceae): A Comprehensive Review of Traditional Uses,
phytochemistry, pharmacology, resource utilization and toxicity. J
Ethnopharmacol. 2022 Nov 15;298:115645. doi: 10.1016/j.jep.2022.115645. Epub
2022 Aug 19. PMID: 35988840.

36: Di YL, Yu Y, Zhao SJ, Huang N, Fei XC, Yao DD, Ai L, Lyu JH, He RQ, Li JJ,
Tong ZQ. Formic acid induces hypertension-related hemorrhage in
hSSAO<sup>TG</sup> in mice and human. Exp Neurol. 2022 Aug 18;358:114208. doi:
10.1016/j.expneurol.2022.114208. Epub ahead of print. PMID: 35988700.

37: Li LB, Fan YG, Wu WX, Bai CY, Jia MY, Hu JP, Gao HL, Wang T, Zhong ML, Huang
XS, Guo C. Novel melatonin-trientine conjugate as potential therapeutic agents
for Alzheimer's disease. Bioorg Chem. 2022 Nov;128:106100. doi:
10.1016/j.bioorg.2022.106100. Epub 2022 Aug 17. PMID: 35988518.

38: Goode-Romero G, Dominguez L. Computational study of the conformational
ensemble of CX3C chemokine receptor 1 (CX3CR1) and its interactions with
antagonist and agonist ligands. J Mol Graph Model. 2022 Dec;117:108278. doi:
10.1016/j.jmgm.2022.108278. Epub 2022 Aug 7. PMID: 35988439.

39: Li X, Tian P, Hu X. Association of Met/Val polymorphism of BDNF gene with
Alzheimer's disease in Chinese patients. Cell Mol Biol (Noisy-le-grand). 2022
Apr 30;68(4):46-51. doi: 10.14715/cmb/2022.68.4.6. PMID: 35988269.

40: Dorey CK, Gierhart D, Fitch KA, Crandell I, Craft NE. Low Xanthophylls,
Retinol, Lycopene, and Tocopherols in Grey and White Matter of Brains with
Alzheimer's Disease. J Alzheimers Dis. 2022 Aug 16. doi: 10.3233/JAD-220460.
Epub ahead of print. PMID: 35988225.

41: Yang J, Oveisgharan S, Liu X, Wilson RS, Bennett DA, Buchman AS. Risk Models
Based on Non-Cognitive Measures May Identify Presymptomatic Alzheimer's Disease.
J Alzheimers Dis. 2022 Aug 17. doi: 10.3233/JAD-220446. Epub ahead of print.
PMID: 35988224.

42: Miao Y, Cui L, Li J, Chen Y, Xie X, Guo Q. Cognitive Improvement After
Multi-Domain Lifestyle Interventions in an APOE ɛ4 Homozygous Carrier with Mild
Cognitive Impairment: A Case Report and Literature Review. J Alzheimers Dis.
2022 Aug 16. doi: 10.3233/JAD-220374. Epub ahead of print. PMID: 35988223.

43: Creavin S, Fish M, Bayer A, Gallacher J, Ben-Shlomo Y. Decline in Cognition
from Mid-Life Improves Specificity of Mini-Mental State Examination: Diagnostic
Test Accuracy in Caerphilly Prospective Study (CaPs). J Alzheimers Dis. 2022 Aug
18. doi: 10.3233/JAD-220345. Epub ahead of print. PMID: 35988222.

44: Liu S, Liu C, Hu W, Ji Y. Frequency, Severity, and Duration of Autonomic
Symptoms in Patients of Prodromal Dementia with Lewy Bodies. J Alzheimers Dis.
2022 Aug 17. doi: 10.3233/JAD-220275. Epub ahead of print. PMID: 35988221.

45: Ooi S, Patel SK, Eratne D, Kyndt C, Reidy N, Lewis C, Lee SCM, Darby D,
Brodtmann A. Plasma Neurofilament Light Chain and Clinical Diagnosis in
Frontotemporal Dementia Syndromes. J Alzheimers Dis. 2022 Aug 17. doi:
10.3233/JAD-220272. Epub ahead of print. PMID: 35988220.

46: Yoshida K, Seo M, Luo Y, Sahker E, Cipriani A, Leucht S, Iwatsubo T,
Efthimiou O, Furukawa TA. Personalized Prediction of Alzheimer's Disease and Its
Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of
Eight Randomized Controlled Trials. J Alzheimers Dis. 2022 Aug 16. doi:
10.3233/JAD-220263. Epub ahead of print. PMID: 35988219.

47: Dartora CM, de Moura LV, Koole M, Marques da Silva AM; Alzheimer’s Disease
Neuroimaging Initiative. Discriminating Aging Cognitive Decline Spectrum Using
PET and Magnetic Resonance Image Features. J Alzheimers Dis. 2022 Aug 16. doi:
10.3233/JAD-215164. Epub ahead of print. PMID: 35988218.

48: Lu Y; Alzheimer’s Disease Neuroimaging Initiative. Cerebrospinal fluid
growth-associated protein 43 levels in patients with progressive and stable mild
cognitive impairment. Aging Clin Exp Res. 2022 Aug 21. doi:
10.1007/s40520-022-02202-z. Epub ahead of print. PMID: 35988117.

49: Mydlikowska-Śmigórska A, Śmigórski K, Szcześniak D, Rymaszewska J. Can
olfactory training support improvement of memory functioning in patients with
mild cognitive disorders? Psychiatr Pol. 2022 Apr 30;56(2):405-416. English,
Polish. doi: 10.12740/PP/OnlineFirst/125573. Epub 2022 Apr 30. PMID: 35988083.

50: Frikke-Schmidt R, Hegazy SH, Rasmussen IJ, Nordestgaard BG, Tybjaerg-Hansen
A, Thomassen JQ. Observational and genetic studies of C-reactive protein levels
and risk of Alzheimer's disease. Alzheimers Dement. 2022 Aug 21. doi:
10.1002/alz.12742. Epub ahead of print. PMID: 35988061.

51: Burgess S. "C-reactive protein levels and risk of dementia": Subgroup
analyses in Mendelian randomization are likely to be misleading. Alzheimers
Dement. 2022 Aug 21. doi: 10.1002/alz.12743. Epub ahead of print. PMID:
35988060.

52: Xu R, Davis PB. The effect of different SARS-CoV-2 variants: Reply.
Alzheimers Dement. 2022 Aug 21. doi: 10.1002/alz.12746. Epub ahead of print.
PMID: 35988058.

53: Hsu CK, Lai CC. The effect of different SARS-CoV-2 variants. Alzheimers
Dement. 2022 Aug 21. doi: 10.1002/alz.12766. Epub ahead of print. PMID:
35988054.

54: Cai A, Liu N, Lin Z, Li X, Wang J, Wu Y, Gao K, Jiang Y. In Vitro Effects of
Acitretin on Human Neuronal SH-SY5Y Cells. Neurochem Res. 2022 Aug 20. doi:
10.1007/s11064-022-03716-8. Epub ahead of print. PMID: 35987975.

55: Bhatia S, Singh M, Singh T, Singh V. Scrutinizing the Therapeutic Potential
of PROTACs in the Management of Alzheimer's Disease. Neurochem Res. 2022 Aug 20.
doi: 10.1007/s11064-022-03722-w. Epub ahead of print. PMID: 35987974.

56: Frontzkowski L, Ewers M, Brendel M, Biel D, Ossenkoppele R, Hager P, Steward
A, Dewenter A, Römer S, Rubinski A, Buerger K, Janowitz D, Binette AP, Smith R,
Strandberg O, Carlgren NM, Dichgans M, Hansson O, Franzmeier N. Earlier
Alzheimer's disease onset is associated with tau pathology in brain hub regions
and facilitated tau spreading. Nat Commun. 2022 Aug 20;13(1):4899. doi:
10.1038/s41467-022-32592-7. PMID: 35987901; PMCID: PMC9392750.

57: Tautvydaitė D, Adam-Darqué A, Andryszak P, Poitrine L, Ptak R, Frisoni GB,
Schnider A. Deficient Novelty Detection and Encoding in Early Alzheimer's
Disease: An ERP Study. Brain Topogr. 2022 Aug 20. doi:
10.1007/s10548-022-00908-x. Epub ahead of print. PMID: 35987832.

58: Wei Z, Zeng K, Hu J, Li X, Huang F, Zhang B, Wang JZ, Liu R, Li HL, Wang X.
USP10 deubiquitinates Tau, mediating its aggregation. Cell Death Dis. 2022 Aug
20;13(8):726. doi: 10.1038/s41419-022-05170-4. PMID: 35987808; PMCID:
PMC9392799.

59: Cuddy LK, Alia AO, Salvo MA, Chandra S, Grammatopoulos TN, Justman CJ,
Lansbury PT Jr, Mazzulli JR, Vassar R. Farnesyltransferase inhibitor LNK-754
attenuates axonal dystrophy and reduces amyloid pathology in mice. Mol
Neurodegener. 2022 Aug 20;17(1):54. doi: 10.1186/s13024-022-00561-9. PMID:
35987691; PMCID: PMC9392365.

60: Weissberger GH, Lim AC, Mosqueda L, Schoen J, Axelrod J, Nguyen AL, Wilber
KH, Esquivel RS, Han SD. Elder abuse in the COVID-19 era based on calls to the
National Center on Elder Abuse resource line. BMC Geriatr. 2022 Aug
20;22(1):689. doi: 10.1186/s12877-022-03385-w. PMID: 35987616; PMCID:
PMC9392067.

61: De Vlieger L, Vandenbroucke RE, Van Hoecke L. Recent insights into viral
infections as a trigger and accelerator in alzheimer's disease. Drug Discov
Today. 2022 Aug 18;27(11):103340. doi: 10.1016/j.drudis.2022.103340. Epub ahead
of print. PMID: 35987492; PMCID: PMC9385395.

62: An L, Chen J, Chen P, Zhang C, He T, Chen C, Zhou JH, Yeo BTT; Alzheimer's
Disease Neuroimaging Initiative; Australian Imaging Biomarkers and Lifestyle
Study of Aging. Goal-specific brain MRI harmonization. Neuroimage. 2022 Aug
17;263:119570. doi: 10.1016/j.neuroimage.2022.119570. Epub ahead of print. PMID:
35987490.

63: Chaudhary A, Chaurasia PK, Kushwaha S, Chauhan P, Chawade A, Mani A.
Correlating multi-functional role of cold shock domain proteins with
intrinsically disordered regions. Int J Biol Macromol. 2022 Aug 18;220:743-753.
doi: 10.1016/j.ijbiomac.2022.08.100. Epub ahead of print. PMID: 35987358.

64: Pesaresi A, Lamba D, Vezenkov L, Tsekova D, Lozanov V. Kinetic and
structural studies on the inhibition of acetylcholinesterase and
butyrylcholinesterase by a series of multitarget-directed galantamine-peptide
derivatives. Chem Biol Interact. 2022 Sep 25;365:110092. doi:
10.1016/j.cbi.2022.110092. Epub 2022 Aug 18. PMID: 35987277.

65: Adaikkan C, Wang J, Abdelaal K, Middleton SJ, Bozzelli PL, Wickersham IR,
McHugh TJ, Tsai LH. Alterations in a cross-hemispheric circuit associates with
novelty discrimination deficits in mouse models of neurodegeneration. Neuron.
2022 Aug 17:S0896-6273(22)00668-7. doi: 10.1016/j.neuron.2022.07.023. Epub ahead
of print. PMID: 35987206.

66: Traxler L, Herdy JR, Stefanoni D, Eichhorner S, Pelucchi S, Szücs A,
Santagostino A, Kim Y, Agarwal RK, Schlachetzki JCM, Glass CK, Lagerwall J,
Galasko D, Gage FH, D'Alessandro A, Mertens J. Warburg-like metabolic
transformation underlies neuronal degeneration in sporadic Alzheimer's disease.
Cell Metab. 2022 Sep 6;34(9):1248-1263.e6. doi: 10.1016/j.cmet.2022.07.014. Epub
2022 Aug 19. PMID: 35987203; PMCID: PMC9458870.

67: Guo J, Cheng M, Liu P, Cao D, Luo J, Wan Y, Fang Y, Jin Y, Xie SS, Liu J. A
multi-target directed ligands strategy for the treatment of Alzheimer's disease:
Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and
Nrf2 activator. Eur J Med Chem. 2022 Nov 15;242:114630. doi:
10.1016/j.ejmech.2022.114630. Epub 2022 Aug 11. PMID: 35987018.

68: Liu M, Chen C, Gao K, Gao F, Qin C, Yuan Q, Zhang H, Zhuang L, Wang P.
Neuronal network-based biomimetic chip for long-term detection of olfactory
dysfunction model in early-stage Alzheimer's disease. Biosens Bioelectron. 2022
Nov 15;216:114619. doi: 10.1016/j.bios.2022.114619. Epub 2022 Aug 7. PMID:
35986984.

69: Lane HY, Lin CH. Diagnosing Alzheimer's disease specifically and sensitively
with pLG72 and cystine/glutamate antiporter SLC7A11 as blood biomarkers. Int J
Neuropsychopharmacol. 2022 Aug 20:pyac053. doi: 10.1093/ijnp/pyac053. Epub ahead
of print. PMID: 35986919.

70: Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in
Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
Inflammation. 2022 Aug 20. doi: 10.1007/s10753-022-01721-1. Epub ahead of print.
PMID: 35986874.

71: Sanaie S, Nikanfar S, Kalekhane ZY, Azizi-Zeinalhajlou A, Sadigh-Eteghad S,
Araj-Khodaei M, Ayati MH, Andalib S. Saffron as a promising therapy for diabetes
and Alzheimer's disease: mechanistic insights. Metab Brain Dis. 2022 Aug 20.
doi: 10.1007/s11011-022-01059-5. Epub ahead of print. PMID: 35986812.

72: Zhang Q, Yan X, Du J, Chen Z, Chang C. Diffusion Tensor Imaging as a Tool to
Evaluate the Cognitive Function of Patients With Vascular Dementia: A Meta-
Analysis. Neurologist. 2022 Aug 19. doi: 10.1097/NRL.0000000000000461. Epub
ahead of print. PMID: 35986673.

73: El Haj M, Allain P, Boutoleau Bretonnière C, Chapelet G, Antoine P, Gallouj
K. Empathy of individuals with Alzheimer's disease (AD) toward other AD
patients. J Clin Exp Neuropsychol. 2022 May;44(4):293-301. doi:
10.1080/13803395.2022.2110573. Epub 2022 Aug 19. PMID: 35986554.

74: Moghadam MT, Mojtahedi A, Bakhshayesh B, Babakhani S, Ajorloo P, Shariati A,
Mirzaei M, Heidarzadeh S, Jazi FM. The effect of bacterial composition shifts in
the oral microbiota on Alzheimer's disease. Curr Mol Med. 2022 Aug 19. doi:
10.2174/1566524023666220819140748. Epub ahead of print. PMID: 35986539.

75: Ikram M, Rasheed S. Genetics of Dravet Syndrome and its Targeted Therapy by
Nanomedicine: A Roadmap for Future Treatment of Drug Resistant Seizures. Curr
Mol Pharmacol. 2022 Aug 19. doi: 10.2174/1874467215666220819143105. Epub ahead
of print. PMID: 35986530.

76: Inaba Y, Iwamoto S, Nakayama K. Genome-wide DNA methylation status of
Mongolians exhibits signs of cellular stress response related to their nomadic
lifestyle. J Physiol Anthropol. 2022 Aug 19;41(1):30. doi:
10.1186/s40101-022-00305-0. PMID: 35986394; PMCID: PMC9388360.

77: Fu QH, Pei J, Zhou HG, Wang T, Zhan YJ, Tao L, Xu J, Zhou Q, Wang LY. Effect
of acupuncture with donepezil based on syndrome differentiation on cognitive
function in patients with mild-to-moderate Alzheimer's disease: a study protocol
for a multicenter randomized controlled trial. Trials. 2022 Aug 19;23(1):695.
doi: 10.1186/s13063-022-06532-1. PMID: 35986297; PMCID: PMC9389745.

78: Ganz T, Fainstein N, Ben-Hur T. When the infectious environment meets the AD
brain. Mol Neurodegener. 2022 Aug 19;17(1):53. doi: 10.1186/s13024-022-00559-3.
PMID: 35986296; PMCID: PMC9388962.

79: Pinyopornpanish K, Soontornpun A, Wongpakaran T, Wongpakaran N, Tanprawate
S, Pinyopornpanish K, Nadsasarn A, Pinyopornpanish M. Impact of behavioral and
psychological symptoms of Alzheimer's disease on caregiver outcomes. Sci Rep.
2022 Aug 19;12(1):14138. doi: 10.1038/s41598-022-18470-8. PMID: 35986203; PMCID:
PMC9391353.

80: Jeong SH, Cha J, Park M, Jung JH, Ye BS, Sohn YH, Chung SJ, Lee PH.
Association of Enlarged Perivascular Spaces With Amyloid Burden and Cognitive
Decline in Alzheimer Disease Continuum. Neurology. 2022 Aug
19:10.1212/WNL.0000000000200989. doi: 10.1212/WNL.0000000000200989. Epub ahead
of print. PMID: 35985826.

81: Duggan MR, Peng Z, An Y, Kitner Triolo MH, Shafer AT, Davatzikos C, Erus G,
Karikkineth A, Lewis A, Moghekar A, Walker KA. Herpes Viruses in the Baltimore
Longitudinal Study of Aging: Associations With Brain Volumes, Cognitive
Performance, and Plasma Biomarkers. Neurology. 2022 Aug
19:10.1212/WNL.0000000000201036. doi: 10.1212/WNL.0000000000201036. Epub ahead
of print. PMID: 35985823.

82: Xi J, Zhang Z, Wang Z, Wu Q, He Y, Xu Y, Ding Z, Zhao H, Da H, Zhang F, Zhao
H, Fang J. Hinokitiol functions as a ferroptosis inhibitor to confer
neuroprotection. Free Radic Biol Med. 2022 Sep;190:202-215. doi:
10.1016/j.freeradbiomed.2022.08.011. Epub 2022 Aug 17. PMID: 35985562.

83: Poddar NK, Agarwal D, Agrawal Y, Wijayasinghe YS, Mukherjee A, Khan S.
Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's
disease: A current update on molecular mechanisms and combination therapy.
Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166524. doi:
10.1016/j.bbadis.2022.166524. Epub 2022 Aug 17. PMID: 35985445.

84: Islam F, Islam MM, Khan Meem AF, Nafady MH, Islam MR, Akter A, Mitra S,
Alhumaydhi FA, Emran TB, Khusro A, Simal-Gandara J, Eftekhari A, Karimi F,
Baghayeri M. Multifaceted role of polyphenols in the treatment and management of
neurodegenerative diseases. Chemosphere. 2022 Nov;307(Pt 3):136020. doi:
10.1016/j.chemosphere.2022.136020. Epub 2022 Aug 16. PMID: 35985383.

85: Shi DD, Savani MR, Levitt MM, Wang AC, Endress JE, Bird CE, Buehler J,
Stopka SA, Regan MS, Lin YF, Puliyappadamba VT, Gao W, Khanal J, Evans L, Lee
JH, Guo L, Xiao Y, Xu M, Huang B, Jennings RB, Bonal DM, Martin-Sandoval MS,
Dang T, Gattie LC, Cameron AB, Lee S, Asara JM, Kornblum HI, Mak TW, Looper RE,
Nguyen QD, Signoretti S, Gradl S, Sutter A, Jeffers M, Janzer A, Lehrman MA,
Zacharias LG, Mathews TP, Losman JA, Richardson TE, Cahill DP, DeBerardinis RJ,
Ligon KL, Xu L, Ly P, Agar NYR, Abdullah KG, Harris IS, Kaelin WG Jr, McBrayer
SK. De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant
glioma. Cancer Cell. 2022 Sep 12;40(9):939-956.e16. doi:
10.1016/j.ccell.2022.07.011. Epub 2022 Aug 18. PMID: 35985343; PMCID:
PMC9515386.

86: Di Benedetto M, Carrara F, Tafuri B, Nigro S, De Blasi R, Falchi F, Gennaro
C, Gigli G, Logroscino G, Amato G; Frontotemporal Lobar Degeneration
Neuroimaging Initiative. Deep networks for behavioral variant frontotemporal
dementia identification from multiple acquisition sources. Comput Biol Med. 2022
Sep;148:105937. doi: 10.1016/j.compbiomed.2022.105937. Epub 2022 Aug 8. PMID:
35985188.

87: Shellikeri S, Cho S, Cousins KAQ, Liberman M, Howard E, Balganorth Y,
Weintraub D, Spindler M, Deik A, Lee EB, Trojanowski JQ, Irwin D, Wolk D,
Grossman M, Nevler N. Natural speech markers of Alzheimer's disease co-pathology
in Lewy body dementias. Parkinsonism Relat Disord. 2022 Sep;102:94-100. doi:
10.1016/j.parkreldis.2022.07.023. Epub 2022 Aug 6. PMID: 35985146.

88: Corriveau-Lecavalier N, Décarie-Labbé L, Mellah S, Belleville S, Rajah MN;
Consortium for the Early Identification of Alzheimer's Disease-Quebec (CIMA-Q).
Sex differences in patterns of associative memory-related activation in
individuals at risk of Alzheimer's disease. Neurobiol Aging. 2022
Nov;119:89-101. doi: 10.1016/j.neurobiolaging.2022.07.007. Epub 2022 Jul 24.
PMID: 35985098.

89: Gambella E, Valenza S, Giulietti MV, Gagliardi C, Civerchia P, Fabbietti P,
Lattanzio F, Pelliccioni G. "The Community That Takes Care of Itself": A
Feasibility Study to Support Families Caring for a Loved One With Alzheimer
Disease. Fam Community Health. 2022 Oct-Dec 01;45(4):238-246. doi:
10.1097/FCH.0000000000000333. PMID: 35985024.

90: Graves LV, Churchill EG, Williams ME, Van Etten EJ, Bondi MW, Salmon DP,
Corey-Bloom J, Delis DC, Gilbert PE. Source recognition discriminability
impairment in Huntington's versus Alzheimer's disease: Evidence from the CVLT-3.
Appl Neuropsychol Adult. 2022 Aug 19:1-6. doi: 10.1080/23279095.2022.2112682.
Epub ahead of print. PMID: 35984776.

91: Piette JD, Roberts JS, Marinec N, Chen J, Yon S, Maly M, Swalwell K,
Hampstead B. Providing a Purposeful and Stimulating Volunteer Opportunity for
Older Adults With Mild Cognitive Impairment: A Pilot Study. Alzheimer Dis Assoc
Disord. 2022 Aug 19. doi: 10.1097/WAD.0000000000000528. Epub ahead of print.
PMID: 35984743.

92: Liu Z, Grant J, Simpson SP, Khattak A, Anderson JG, Gao Z, Zhao X. Driving
Ability Evaluation and Rehabilitation for People With Alzheimer's Disease and
Related Dementias. Alzheimer Dis Assoc Disord. 2022 Aug 19. doi:
10.1097/WAD.0000000000000524. Epub ahead of print. PMID: 35984740.

93: Comparison table: Drugs for Alzheimer's disease. Med Lett Drugs Ther. 2022
Aug 22;64(1657):e136-e137. PMID: 35984643.

94: Drugs for cognitive loss and dementia. Med Lett Drugs Ther. 2022 Aug
22;64(1657):129-136. PMID: 35984642.

95: Liu H, Zhong L, Dai Q, Zhang Y, Yang J. Astragalin alleviates cognitive
deficits and neuronal damage in SAMP8 mice through upregulating estrogen
receptor expression. Metab Brain Dis. 2022 Aug 19. doi:
10.1007/s11011-022-01045-x. Epub ahead of print. PMID: 35984596.

96: Mishra R, Phan T, Kumar P, Morrissey Z, Gupta M, Hollands C, Shetti A, Lopez
KL, Maienschein-Cline M, Suh H, Hen R, Lazarov O. Augmenting neurogenesis
rescues memory impairments in Alzheimer's disease by restoring the memory-
storing neurons. J Exp Med. 2022 Sep 5;219(9):e20220391. doi:
10.1084/jem.20220391. Epub 2022 Aug 19. PMID: 35984475; PMCID: PMC9399756.

97: Li XL, Gao RX, Zhang Q, Li A, Cai LN, Zhao WW, Gao SL, Wang Y, Yue J. A
bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on
Web of Science. Medicine (Baltimore). 2022 Aug 19;101(33):e30079. doi:
10.1097/MD.0000000000030079. PMID: 35984119; PMCID: PMC9388009.

98: Coe AB, Zhang T, Zullo AR, Gerlach LB, Thomas KS, Daiello LA, Varma H, Lo D,
Joshi R, Shireman TI, Bynum JPW. Psychotropic medication prescribing in assisted
living and nursing home residents with dementia after the National Partnership.
J Am Geriatr Soc. 2022 Aug 19. doi: 10.1111/jgs.18004. Epub ahead of print.
PMID: 35984088.

99: Jain AK, Gupta A, Karthikeyan C, Trivedi P, Konar AD. Substituent
Orchestration in Dimethylquinoxaline Derivatives: A Tool for Fishing Out
Appropriate CDK5 Inhibitors as Potential Therapeutics for Alzheimer's. Chem
Biodivers. 2022 Sep;19(9):e202200116. doi: 10.1002/cbdv.202200116. Epub 2022 Aug
19. PMID: 35983935.

100: Kısa D, Imamoglu R, Kaya Z, Taskin-Tok T, Taslimi P. Turanecio
hypochionaeus: Determination of Its Polyphenol Contents, and Bioactivities
Potential Assisted with in Silico Studies. Chem Biodivers. 2022
Sep;19(9):e202200109. doi: 10.1002/cbdv.202200109. Epub 2022 Sep 5. PMID:
35983912.

101: Long Y, Li D, Yu S, Shi A, Deng J, Wen J, Li XQ, Ma Y, Zhang YL, Liu SY,
Wan JY, Li N, Yang M, Han L. Medicine-food herb: <i>Angelica sinensis</i>, a
potential therapeutic hope for Alzheimer's disease and related complications.
Food Funct. 2022 Aug 30;13(17):8783-8803. doi: 10.1039/d2fo01287a. PMID:
35983893.

102: Kumar S, Ayyannan SR. Identification of new small molecule monoamine
oxidase-B inhibitors through pharmacophore-based virtual screening, molecular
docking and molecular dynamics simulation studies. J Biomol Struct Dyn. 2022 Aug
18:1-22. doi: 10.1080/07391102.2022.2112082. Epub ahead of print. PMID:
35983603.

103: Sethi M, Rani S, Singh A, Mazón JLV. A CAD System for Alzheimer's Disease
Classification Using Neuroimaging MRI 2D Slices. Comput Math Methods Med. 2022
Aug 9;2022:8680737. doi: 10.1155/2022/8680737. PMID: 35983528; PMCID:
PMC9381208.

104: Li HL, Zhang SY, Ren YS, Zhou JC, Zhou YX, Huang WZ, Piao XH, Yang ZY, Wang
SM, Ge YW. Identification of ellagic acid and urolithins as natural inhibitors
of Aβ<sub>25-35</sub>-induced neurotoxicity and the mechanism predication using
network pharmacology analysis and molecular docking. Front Nutr. 2022 Aug
2;9:966276. doi: 10.3389/fnut.2022.966276. PMID: 35983489; PMCID: PMC9378864.

105: Kuramoto E, Kitawaki A, Yagi T, Kono H, Matsumoto SE, Hara H, Ohyagi Y,
Iwai H, Yamanaka A, Goto T. Development of a system to analyze oral frailty
associated with Alzheimer's disease using a mouse model. Front Aging Neurosci.
2022 Aug 2;14:935033. doi: 10.3389/fnagi.2022.935033. PMID: 35983379; PMCID:
PMC9380890.

106: Fan L, Zhaohong X, Xiangxue W, Yingying X, Xiao Z, Xiaoyan Z, Jieke Y, Chao
L. Melatonin Ameliorates the Progression of Alzheimer's Disease by Inducing TFEB
Nuclear Translocation, Promoting Mitophagy, and Regulating NLRP3 Inflammasome
Activity. Biomed Res Int. 2022 Aug 9;2022:8099459. doi: 10.1155/2022/8099459.
PMID: 35983247; PMCID: PMC9381268.

107: Li W, Jiang J, Zou X, Zhang Y, Sun M, Jia Z, Li W, Xu J. The
characteristics of arterial spin labeling cerebral blood flow in patients with
subjective cognitive decline: The Chinese imaging, biomarkers, and lifestyle
study. Front Neurosci. 2022 Aug 2;16:961164. doi: 10.3389/fnins.2022.961164.
PMID: 35983224; PMCID: PMC9379247.

108: Amini M, Pedram MM, Moradi A, Jamshidi M, Ouchani M. GC-CNNnet: Diagnosis
of Alzheimer's Disease with PET Images Using Genetic and Convolutional Neural
Network. Comput Intell Neurosci. 2022 Aug 9;2022:7413081. doi:
10.1155/2022/7413081. PMID: 35983158; PMCID: PMC9381254.

109: Kaltschmidt B, Helweg LP, Greiner JFW, Kaltschmidt C. NF-κB in
neurodegenerative diseases: Recent evidence from human genetics. Front Mol
Neurosci. 2022 Aug 2;15:954541. doi: 10.3389/fnmol.2022.954541. PMID: 35983068;
PMCID: PMC9380593.

110: Nwosu A, Boardman S, Husain MM, Doraiswamy PM. Digital therapeutics for
mental health: Is attrition the Achilles heel? Front Psychiatry. 2022 Aug
5;13:900615. doi: 10.3389/fpsyt.2022.900615. PMID: 35982936; PMCID: PMC9380224.

111: Edelen MO, Harrison JM, Rodriguez A, Weir R, Lai JS, Langer MM, Hanmer J.
Evaluation of PROMIS Cognitive Function Scores and Correlates in a Clinical
Sample of Older Adults. Gerontol Geriatr Med. 2022 Aug 13;8:23337214221119057.
doi: 10.1177/23337214221119057. PMID: 35982856; PMCID: PMC9379962.

112: Manchanda S, Galan-Acosta L, Abelein A, Tambaro S, Chen G, Nilsson P,
Johansson J. Intravenous treatment with a molecular chaperone designed against
β-amyloid toxicity improves Alzheimer's disease pathology in mouse models. Mol
Ther. 2022 Aug 17:S1525-0016(22)00498-1. doi: 10.1016/j.ymthe.2022.08.010. Epub
ahead of print. PMID: 35982621.

113: Conca F, Esposito V, Rundo F, Quaranta D, Muscio C, Manenti R, Caruso G,
Lucca U, Galbussera AA, Di Tella S, Baglio F, L'Abbate F, Canu E, Catania V,
Filippi M, Mattavelli G, Poletti B, Silani V, Lodi R, De Matteis M, Stanzani
Maserati M, Arighi A, Rotondo E, Tanzilli A, Pace A, Garramone F, Cavaliere C,
Pardini M, Rizzetto C, Sorbi S, Perri R, Tiraboschi P, Canessa N, Cotelli M,
Ferri R, Weintraub S, Marra C, Tagliavini F, Catricalà E, Cappa SF. Italian
adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB
1.0): development and normative data. Alzheimers Res Ther. 2022 Aug
19;14(1):113. doi: 10.1186/s13195-022-01056-x. PMID: 35982477; PMCID:
PMC9389755.

114: Ren Z, Chu C, Pang Y, Cai H, Jia L. A circular RNA blood panel that
differentiates Alzheimer's disease from other dementia types. Biomark Res. 2022
Aug 18;10(1):63. doi: 10.1186/s40364-022-00405-0. PMID: 35982472; PMCID:
PMC9389828.

115: Devinney MJ, VanDusen KW, Kfouri JM, Avasarala P, Spector AR, Mathew JP,
Berger M. The potential link between obstructive sleep apnea and postoperative
neurocognitive disorders: current knowledge and possible mechanisms. Can J
Anaesth. 2022 Oct;69(10):1272-1287. English. doi: 10.1007/s12630-022-02302-4.
Epub 2022 Aug 18. PMID: 35982354.

116: Vicente-Zurdo D, Rodríguez-Blázquez S, Gómez-Mejía E, Rosales-Conrado N,
León-González ME, Madrid Y. Neuroprotective activity of selenium nanoparticles
against the effect of amino acid enantiomers in Alzheimer's disease. Anal
Bioanal Chem. 2022 Aug 19. doi: 10.1007/s00216-022-04285-z. Epub ahead of print.
PMID: 35982253.

117: Dehghan Manshadi M, Setoodeh P, Zare H. Rapid-SL identifies synthetic
lethal sets with an arbitrary cardinality. Sci Rep. 2022 Aug 18;12(1):14022.
doi: 10.1038/s41598-022-18177-w. PMID: 35982201; PMCID: PMC9388495.

118: Smith L, Pizzol D, López Sánchez GF, Kostev K, Oh H, Jacob L, Veronese N,
Underwood BR, Butler L, Barnett Y, Tully MA, Koyanagi A. Association between
cooking fuels and mild cognitive impairment among older adults from six low- and
middle-income countries. Sci Rep. 2022 Aug 18;12(1):14055. doi:
10.1038/s41598-022-17216-w. PMID: 35982103; PMCID: PMC9388480.

119: C Silva T, Young JI, Zhang L, Gomez L, Schmidt MA, Varma A, Chen XS, Martin
ER, Wang L. Cross-tissue analysis of blood and brain epigenome-wide association
studies in Alzheimer's disease. Nat Commun. 2022 Aug 18;13(1):4852. doi:
10.1038/s41467-022-32475-x. PMID: 35982059; PMCID: PMC9388493.

120: Coors A, Imtiaz MA, Boenniger MM, Aziz NA, Ettinger U, Breteler MMB.
Associations of genetic liability for Alzheimer's disease with cognition and eye
movements in a large, population-based cohort study. Transl Psychiatry. 2022 Aug
19;12(1):337. doi: 10.1038/s41398-022-02093-8. PMID: 35982049; PMCID:
PMC9388528.

121: Dorninger F, Vaz FM, Waterham HR, Klinken JBV, Zeitler G, Forss-Petter S,
Berger J, Wiesinger C. Ether lipid transfer across the blood-brain and placental
barriers does not improve by inactivation of the most abundant ABC transporters.
Brain Res Bull. 2022 Oct 15;189:69-79. doi: 10.1016/j.brainresbull.2022.08.006.
Epub 2022 Aug 15. PMID: 35981629.

122: Tsolaki M, Sia E, Giannouli V. Anesthesia and dementia: an up-to-date
review of the existing literature. Appl Neuropsychol Adult. 2022 Aug 18:1-10.
doi: 10.1080/23279095.2022.2110871. Epub ahead of print. PMID: 35981552.

123: Chandregowda A, Clark HM, Machulda MM, Pham NTT, Lowe VJ, Josephs KA,
Whitwell JL. A Case of Atypical Alzheimer Disease With Clinical Manifestation
That Straddled the Boundary Between Primary Progressive Aphasia and Posterior
Cortical Atrophy. Neurologist. 2022 Aug 18. doi: 10.1097/NRL.0000000000000458.
Epub ahead of print. PMID: 35981305.

124: Dong H, Zhao L, Chen Y, Li M, Chen W, Wang Y, Wei X, Zhang Y, Zhou Y, Xu M.
Dual-Ligand Near-Infrared Luminescent Lanthanide-Based Metal-Organic Framework
Coupled with <i>In Vivo</i> Microdialysis for Highly Sensitive Ratiometric
Detection of Zn<sup>2+</sup> in a Mouse Model of Alzheimer's Disease. Anal Chem.
2022 Aug 30;94(34):11940-11948. doi: 10.1021/acs.analchem.2c02898. Epub 2022 Aug
18. PMID: 35981232.

125: Xue LL, Huangfu LR, Du RL, Chen L, Yu CY, Xiong LL, Wang TH. The age-
specific pathological changes of β-amyloid plaques in the cortex and hippocampus
of APP/PS1 transgenic AD mice. Neurol Res. 2022 Aug 18:1-13. doi:
10.1080/01616412.2022.2112368. Epub ahead of print. PMID: 35981107.

126: Liu J, Singh AK, Lin CT. Predicting the Quality of Spatial Learning via
Virtual Global Landmarks. IEEE Trans Neural Syst Rehabil Eng. 2022;30:2418-2425.
doi: 10.1109/TNSRE.2022.3199713. Epub 2022 Sep 1. PMID: 35981074.

127: Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan
R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han
N, Zack R, Van Deerlin VM, Tropea TF, Luk KC, Lee EB, Weintraub D, Chen-Plotkin
AS. GPNMB confers risk for Parkinson's disease through interaction with
α-synuclein. Science. 2022 Aug 19;377(6608):eabk0637. doi:
10.1126/science.abk0637. Epub 2022 Aug 19. PMID: 35981040.

128: Thorp HH. Rethinking the retraction process. Science. 2022 Aug
19;377(6608):793. doi: 10.1126/science.ade3742. Epub 2022 Aug 18. PMID:
35981030.

129: Cooper YA, Teyssier N, Dräger NM, Guo Q, Davis JE, Sattler SM, Yang Z,
Patel A, Wu S, Kosuri S, Coppola G, Kampmann M, Geschwind DH. Functional
regulatory variants implicate distinct transcriptional networks in dementia.
Science. 2022 Aug 19;377(6608):eabi8654. doi: 10.1126/science.abi8654. Epub 2022
Aug 19. PMID: 35981026.

130: Kim SJ, Park SM, Cho HJ, Park JW. Primary headaches increase the risk of
dementias: An 8-year nationwide cohort study. PLoS One. 2022 Aug
18;17(8):e0273220. doi: 10.1371/journal.pone.0273220. PMID: 35980951; PMCID:
PMC9387842.

131: McSorley VE, Howard C, Shah RC, James BD, Boyle PA, Barnes LL. The
Relationship of John Henryism With Cognitive Function and Decline in Older Black
Adults. Psychosom Med. 2022 Sep 1;84(7):766-772. doi:
10.1097/PSY.0000000000001113. Epub 2022 Jul 28. PMID: 35980784; PMCID:
PMC9437121.

132: De Simone MS, Rodini M, De Tollis M, Fadda L, Caltagirone C, Carlesimo GA.
The diagnostic usefulness of experimental memory tasks for detecting subjective
cognitive decline: Preliminary results in an Italian sample. Neuropsychology.
2022 Aug 18. doi: 10.1037/neu0000846. Epub ahead of print. PMID: 35980693.

133: O'Bryant SE, Petersen M, Hall J, Large S, Johnson LA; HABS-HD Study Team.
Plasma Biomarkers of Alzheimer's Disease Are Associated with Physical
Functioning Outcomes Among Cognitively Normal Adults in the Multi-Ethnic HABS-HD
Cohort. J Gerontol A Biol Sci Med Sci. 2022 Aug 18:glac169. doi:
10.1093/gerona/glac169. Epub ahead of print. PMID: 35980599.

134: Ali M, Huarte OU, Heurtaux T, Garcia P, Rodriguez BP, Grzyb K, Halder R,
Skupin A, Buttini M, Glaab E. Single-Cell Transcriptional Profiling and Gene
Regulatory Network Modeling in Tg2576 Mice Reveal Gender-Dependent Molecular
Features Preceding Alzheimer-Like Pathologies. Mol Neurobiol. 2022 Aug 18. doi:
10.1007/s12035-022-02985-2. Epub ahead of print. PMID: 35980567.

135: Coughlin DG, Goodwill VS, Standke HG, Kim Y, Coley N, Pizzo DP, Galasko D,
Kraus A, Hiniker A. Selective tau seeding assays and isoform-specific antibodies
define neuroanatomic distribution of progressive supranuclear palsy pathology
arising in Alzheimer's disease. Acta Neuropathol. 2022 Oct;144(4):789-792. doi:
10.1007/s00401-022-02480-x. Epub 2022 Aug 18. PMID: 35980456; PMCID: PMC9467964.

136: Gupta S, Raskatov JA, Ralston CY. A Hybrid Structural Method for
Investigating Low Molecular Weight Oligomeric Structures of Amyloid Beta.
Chembiochem. 2022 Aug 18:e202200333. doi: 10.1002/cbic.202200333. Epub ahead of
print. PMID: 35980391.

137: Islam M, Shen F, Regmi D, Petersen K, Karim MRU, Du D. Tau liquid-liquid
phase separation: At the crossroads of tau physiology and tauopathy. J Cell
Physiol. 2022 Aug 18. doi: 10.1002/jcp.30853. Epub ahead of print. PMID:
35980344.

138: Chavda VP, Chen Y, Dave J, Chen ZS, Chauhan SC, Yallapu MM, Uversky VN,
Bezbaruah R, Patel S, Apostolopoulos V. COVID-19 and vaccination: myths vs
science. Expert Rev Vaccines. 2022 Sep 1:1-18. doi:
10.1080/14760584.2022.2114900. Epub ahead of print. PMID: 35980281.

139: Park SH, Lee JH, Kim JS, Kim TJ, Shin J, Im JH, Cha B, Lee S, Kwon KS, Shin
YW, Ko SB, Choi SH. Fecal microbiota transplantation can improve cognition in
patients with cognitive decline and <i>Clostridioides difficile</i> infection.
Aging (Albany NY). 2022 Aug 16;14(16):6449-6466. doi: 10.18632/aging.204230.
Epub 2022 Aug 16. PMID: 35980280; PMCID: PMC9467396.

140: He DL, Fan YG, Wang ZY. Energy crisis links to autophagy and ferroptosis in
Alzheimer's disease: current evidence and future avenues. Curr Neuropharmacol.
2022 Aug 17. doi: 10.2174/1570159X20666220817140737. Epub ahead of print. PMID:
35980072.

141: Jaberi KR, Alamdari-Palangi V, Jaberi AR, Esmaeli Z, Shakeri A, Gheibihayat
SM, Tajbakhsh A, Savardashtaki A. The regulation, functions, and signaling of
miR-153 in neurological disorders and its potential as a biomarker and
therapeutic target. Curr Mol Med. 2022 Aug 17. doi:
10.2174/1566524023666220817145638. Epub ahead of print. PMID: 35980063.

142: Wood K, Maharshak I, Koronyo Y, Koronyo-Hamaoui M. [THE RETINA AS A TOOL
FOR EARLY DIAGNOSIS OF ALZHEIMER DISEASE]. Harefuah. 2022 Aug;161(8):523-525.
Hebrew. PMID: 35979573.

143: Xi H, Gan J, Liu S, Wang F, Chen Z, Wang XD, Shi Z, Ji Y. Reproductive
factors and cognitive impairment in natural menopausal women: A cross-sectional
study. Front Endocrinol (Lausanne). 2022 Aug 1;13:893901. doi:
10.3389/fendo.2022.893901. PMID: 35979434; PMCID: PMC9376623.

144: Fan Y, Li M, Wu C, Wu Y, Han J, Wu P, Huang Z, Wang Q, Zhao L, Chen D, Zhu
M. Chronic Cerebral Hypoperfusion Aggravates Parkinson's Disease Dementia-Like
Symptoms and Pathology in 6-OHDA-Lesioned Rat through Interfering with
Sphingolipid Metabolism. Oxid Med Cell Longev. 2022 Aug 8;2022:5392966. doi:
10.1155/2022/5392966. PMID: 35979400; PMCID: PMC9377946.

145: Sun Z, Hou X, Zhang J, Li J, Wu P, Yan L, Qian H. Diagnostic and
Therapeutic Roles of Extracellular Vesicles in Aging-Related Diseases. Oxid Med
Cell Longev. 2022 Aug 8;2022:6742792. doi: 10.1155/2022/6742792. PMID: 35979398;
PMCID: PMC9377967.

146: Sušjan-Leite P, Ramuta TŽ, Boršić E, Orehek S, Hafner-Bratkovič I.
Supramolecular organizing centers at the interface of inflammation and
neurodegeneration. Front Immunol. 2022 Aug 1;13:940969. doi:
10.3389/fimmu.2022.940969. PMID: 35979366; PMCID: PMC9377691.

147: Ponomareva NV, Andreeva TV, Protasova M, Konovalov RN, Krotenkova MV,
Kolesnikova EP, Malina DD, Kanavets EV, Mitrofanov AA, Fokin VF, Illarioshkin
SN, Rogaev EI. Genetic association of apolipoprotein E genotype with EEG alpha
rhythm slowing and functional brain network alterations during normal aging.
Front Neurosci. 2022 Aug 1;16:931173. doi: 10.3389/fnins.2022.931173. PMID:
35979332; PMCID: PMC9376365.

148: Chen T, Su P, Shen Y, Chen L, Mahmud M, Zhao Y, Antoniou G. A dominant set-
informed interpretable fuzzy system for automated diagnosis of dementia. Front
Neurosci. 2022 Aug 1;16:867664. doi: 10.3389/fnins.2022.867664. PMID: 35979331;
PMCID: PMC9376621.

149: Jiang J, Yang C, Ai JQ, Zhang QL, Cai XL, Tu T, Wan L, Wang XS, Wang H, Pan
A, Manavis J, Gai WP, Che C, Tu E, Wang XP, Li ZY, Yan XX. Intraneuronal
sortilin aggregation relative to granulovacuolar degeneration, tau pathogenesis
and sorfra plaque formation in human hippocampal formation. Front Aging
Neurosci. 2022 Aug 1;14:926904. doi: 10.3389/fnagi.2022.926904. PMID: 35978952;
PMCID: PMC9376392.

150: Zhao R, Han X, Zhang H, Liu J, Zhang M, Zhao W, Jiang S, Li R, Cai H, You
H. Association of vitamin E intake in diet and supplements with risk of
dementia: A meta-analysis. Front Aging Neurosci. 2022 Aug 1;14:955878. doi:
10.3389/fnagi.2022.955878. PMID: 35978949; PMCID: PMC9376618.

151: Harrison D, Bock MG, Doedens JR, Gabel CA, Holloway MK, Lewis A, Scanlon J,
Sharpe A, Simpson ID, Smolak P, Wishart G, Watt AP. Discovery and Optimization
of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors.
ACS Med Chem Lett. 2022 Aug 1;13(8):1321-1328. doi:
10.1021/acsmedchemlett.2c00242. PMID: 35978696; PMCID: PMC9377005.

152: Yu T, Sun Z, Cao X, Pang Q, Deng H. Recent trends in T7 phage application
in diagnosis and treatment of various diseases. Int Immunopharmacol. 2022
Sep;110:109071. doi: 10.1016/j.intimp.2022.109071. Epub 2022 Jul 26. PMID:
35978521.

153: Wang Z, Weaver DF. Microglia and microglial-based receptors in the
pathogenesis and treatment of Alzheimer's disease. Int Immunopharmacol. 2022
Sep;110:109070. doi: 10.1016/j.intimp.2022.109070. Epub 2022 Jul 21. PMID:
35978514.

154: Wang J, Liu B, Sun F, Xu Y, Luan H, Yang M, Wang C, Zhang T, Zhou Z, Yan H.
Histamine H3R antagonist counteracts the impaired hippocampal neurogenesis in
Lipopolysaccharide-induced neuroinflammation. Int Immunopharmacol. 2022
Sep;110:109045. doi: 10.1016/j.intimp.2022.109045. Epub 2022 Jul 20. PMID:
35978505.

155: Li W, Liang J, Li S, Wang L, Xu S, Jiang S, Song M, Meng H, Zhai D, Tang L,
Yang Y, Zhang L, Zhang B. Research progress of targeting NLRP3 inflammasome in
peripheral nerve injury and pain. Int Immunopharmacol. 2022 Sep;110:109026. doi:
10.1016/j.intimp.2022.109026. Epub 2022 Jul 22. PMID: 35978503.

156: Kawakita S, Mandal K, Mou L, Mecwan MM, Zhu Y, Li S, Sharma S, Hernandez
AL, Nguyen HT, Maity S, de Barros NR, Nakayama A, Bandaru P, Ahadian S, Kim HJ,
Herculano RD, Holler E, Jucaud V, Dokmeci MR, Khademhosseini A. Organ-On-A-Chip
Models of the Blood-Brain Barrier: Recent Advances and Future Prospects. Small.
2022 Sep;18(39):e2201401. doi: 10.1002/smll.202201401. Epub 2022 Aug 17. PMID:
35978444.

157: Heming M, Börsch AL, Wiendl H, Meyer Zu Hörste G. High-dimensional
investigation of the cerebrospinal fluid to explore and monitor CNS immune
responses. Genome Med. 2022 Aug 17;14(1):94. doi: 10.1186/s13073-022-01097-9.
PMID: 35978442; PMCID: PMC9385102.

158: Gomez-Arboledas A, Carvalho K, Balderrama-Gutierrez G, Chu SH, Liang HY,
Schartz ND, Selvan P, Petrisko TJ, Pan MA, Mortazavi A, Tenner AJ. C5aR1
antagonism alters microglial polarization and mitigates disease progression in a
mouse model of Alzheimer's disease. Acta Neuropathol Commun. 2022 Aug
17;10(1):116. doi: 10.1186/s40478-022-01416-6. PMID: 35978440; PMCID:
PMC9386996.

159: Gelpi E, Baiardi S, Nos C, Dellavalle S, Aldecoa I, Ruiz-Garcia R, Ispierto
L, Escudero D, Casado V, Barranco E, Boltes A, Molina-Porcel L, Bargalló N,
Rossi M, Mammana A, Tiple D, Vaianella L, Stoegmann E, Simonitsch-Klupp I,
Kasprian G, Klotz S, Höftberger R, Budka H, Kovacs GG, Ferrer I, Capellari S,
Sanchez-Valle R, Parchi P. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic
and molecular characterization of a novel subtype of human prion disease. Acta
Neuropathol Commun. 2022 Aug 17;10(1):114. doi: 10.1186/s40478-022-01415-7.
PMID: 35978418; PMCID: PMC9387077.

160: Riboldi GM, Vialle RA, Navarro E, Udine E, de Paiva Lopes K, Humphrey J,
Allan A, Parks M, Henderson B, Astudillo K, Argyrou C, Zhuang M, Sikder T, Oriol
Narcis J, Kumar SD, Janssen W, Sowa A, Comi GP, Di Fonzo A, Crary JF, Frucht SJ,
Raj T. Transcriptome deregulation of peripheral monocytes and whole blood in
GBA-related Parkinson's disease. Mol Neurodegener. 2022 Aug 17;17(1):52. doi:
10.1186/s13024-022-00554-8. PMID: 35978378; PMCID: PMC9386994.

161: Aimo A, Huang L, Tyler A, Barison A, Martini N, Saccaro LF, Roujol S, Masci
PG. Quantitative susceptibility mapping (QSM) of the cardiovascular system:
challenges and perspectives. J Cardiovasc Magn Reson. 2022 Aug 18;24(1):48. doi:
10.1186/s12968-022-00883-z. PMID: 35978351; PMCID: PMC9387036.

162: Singh D. Astrocytic and microglial cells as the modulators of
neuroinflammation in Alzheimer's disease. J Neuroinflammation. 2022 Aug
17;19(1):206. doi: 10.1186/s12974-022-02565-0. PMID: 35978311; PMCID:
PMC9382837.

163: Sakamuri SSVP, Sure VN, Wang X, Bix G, Fonseca VA, Mostany R, Katakam PVG.
Amyloid [Formula: see text] (1-42) peptide impairs mitochondrial respiration in
primary human brain microvascular endothelial cells: impact of dysglycemia and
pre-senescence. Geroscience. 2022 Aug 17. doi: 10.1007/s11357-022-00644-x. Epub
ahead of print. PMID: 35978067.

164: Ngwa DN, Agrawal A. Structurally Altered, Not Wild-Type, Pentameric
C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils. J Immunol. 2022 Sep
15;209(6):1180-1188. doi: 10.4049/jimmunol.2200148. Epub 2022 Aug 17. PMID:
35977795; PMCID: PMC9492646.

165: Dyer O. Alzheimer's: Alleged image manipulation in seminal paper casts
doubt on leading hypothesis of disease. BMJ. 2022 Aug 17;378:o2041. doi:
10.1136/bmj.o2041. PMID: 35977728.

166: Peng X, Fan R, Xie L, Shi X, Wang F, Xu W, Dong K, Zhang S, Ma D, Yu X,
Yang Y. Time-restricted feeding rescues circadian disruption-aggravated
progression of Alzheimer's disease in diabetic mice. J Nutr Biochem. 2022 Aug
15;110:109128. doi: 10.1016/j.jnutbio.2022.109128. Epub ahead of print. PMID:
35977665.

167: Margeta MA, Yin Z, Madore C, Pitts KM, Letcher SM, Tang J, Jiang S,
Gauthier CD, Silveira SR, Schroeder CM, Lad EM, Proia AD, Tanzi RE, Holtzman DM,
Krasemann S, Chen DF, Butovsky O. Apolipoprotein E4 impairs the response of
neurodegenerative retinal microglia and prevents neuronal loss in glaucoma.
Immunity. 2022 Sep 13;55(9):1627-1644.e7. doi: 10.1016/j.immuni.2022.07.014.
Epub 2022 Aug 16. PMID: 35977543; PMCID: PMC9488669.

168: Koblinsky ND, Power KA, Middleton L, Ferland G, Anderson ND. The role of
the gut microbiome in diet and exercise effects on cognition: A review of the
intervention literature. J Gerontol A Biol Sci Med Sci. 2022 Aug 17:glac166.
doi: 10.1093/gerona/glac166. Epub ahead of print. PMID: 35977540.

169: Arnaud L, Benech P, Greetham L, Stephan D, Jimenez A, Jullien N, García-
González L, Tsvetkov PO, Devred F, Sancho-Martinez I, Izpisua Belmonte JC,
Baranger K, Rivera S, Nivet E. APOE4 drives inflammation in human astrocytes via
TAGLN3 repression and NF-κB activation. Cell Rep. 2022 Aug 16;40(7):111200. doi:
10.1016/j.celrep.2022.111200. PMID: 35977506.

170: Forrest SL, Wagner S, Kim A, Kovacs GG. Association of glial tau pathology
and LATE-NC in the ageing brain. Neurobiol Aging. 2022 Nov;119:77-88. doi:
10.1016/j.neurobiolaging.2022.07.010. Epub 2022 Jul 31. PMID: 35977443.

171: Bracher-Smith M, Leonenko G, Baker E, Crawford K, Graham AC, Salih DA,
Howell BW, Hardy J, Escott-Price V. Whole genome analysis in APOE4 homozygotes
identifies the DAB1-RELN pathway in Alzheimer's disease pathogenesis. Neurobiol
Aging. 2022 Nov;119:67-76. doi: 10.1016/j.neurobiolaging.2022.07.009. Epub 2022
Jul 29. PMID: 35977442.

172: Xiang J, Xiang C, Zhou L, Sun M, Feng L, Liu C, Cai L, Gong P. Rational
Design, Synthesis of Fluorescence Probes for Quantitative Detection of Amyloid-β
in Alzheimer's Disease Based on Rhodamine-Metal Complex. Anal Chem. 2022 Aug
30;94(34):11791-11797. doi: 10.1021/acs.analchem.2c01911. Epub 2022 Aug 17.
PMID: 35977343.

173: Festa N, Price M, Moura LMVR, Blacker D, Normand SL, Newhouse JP, Hsu J.
Evaluation of Claims-Based Ascertainment of Alzheimer Disease and Related
Dementias Across Health Care Settings. JAMA Health Forum. 2022 Apr
22;3(4):e220653. doi: 10.1001/jamahealthforum.2022.0653. PMID: 35977320; PMCID:
PMC9034399.

174: Davis MA, Chang CH, Simonton S, Bynum JPW. Trends in US Medicare Decedents'
Diagnosis of Dementia From 2004 to 2017. JAMA Health Forum. 2022 Apr
1;3(4):e220346. doi: 10.1001/jamahealthforum.2022.0346. PMID: 35977316; PMCID:
PMC8976239.

175: Thirukumaran CP, Ricciardi BF, Cai X, Holloway RG, Li Y, Glance LG.
Association of Medicare Mandatory Bundled Payment Reform With Joint Replacement
Surgery Use for Beneficiaries With Alzheimer Disease and Related Dementias. JAMA
Health Forum. 2022 Feb 11;3(2):e215111. doi: 10.1001/jamahealthforum.2021.5111.
PMID: 35977279; PMCID: PMC8903111.

176: Gianattasio KZ, Moghtaderi A, Lupu D, Prather C, Power MC. Evaluation of
Federal Policy Changes to the Hospice Benefit and Use of Hospice for Persons
With ADRD. JAMA Health Forum. 2022 May 6;3(5):e220900. doi:
10.1001/jamahealthforum.2022.0900. PMID: 35977261; PMCID: PMC9077487.

177: Bronskill SE, Maclagan LC, Maxwell CJ, Iaboni A, Jaakkimainen RL, Marras C,
Wang X, Guan J, Harris DA, Emdin A, Jones A, Sourial N, Godard-Sebillotte C,
Vedel I, Austin PC, Swartz RH. Trends in Health Service Use for Canadian Adults
With Dementia and Parkinson Disease During the First Wave of the COVID-19
Pandemic. JAMA Health Forum. 2022 Jan 21;3(1):e214599. doi:
10.1001/jamahealthforum.2021.4599. PMID: 35977228; PMCID: PMC8903126.

178: Cavaillès C, Carrière I, Wagner M, Dartigues JF, Berr C, Dauvilliers Y,
Jaussent I. Trajectories of sleep duration and timing before dementia: a 14-year
follow-up study. Age Ageing. 2022 Aug 2;51(8):afac186. doi:
10.1093/ageing/afac186. PMID: 35977152.

179: Venkataraman AV, Mansur A, Rizzo G, Bishop C, Lewis Y, Kocagoncu E,
Lingford-Hughes A, Huiban M, Passchier J, Rowe JB, Tsukada H, Brooks DJ,
Martarello L, Comley RA, Chen L, Schwarz AJ, Hargreaves R, Gunn RN, Rabiner EA,
Matthews PM. Widespread cell stress and mitochondrial dysfunction occur in
patients with early Alzheimer's disease. Sci Transl Med. 2022 Aug
17;14(658):eabk1051. doi: 10.1126/scitranslmed.abk1051. Epub 2022 Aug 17. PMID:
35976998.

180: Zhang Y, Niu C. Relation of CDC42, Th1, Th2, and Th17 cells with cognitive
function decline in Alzheimer's disease. Ann Clin Transl Neurol. 2022
Sep;9(9):1428-1436. doi: 10.1002/acn3.51643. Epub 2022 Aug 17. PMID: 35976992;
PMCID: PMC9463943.

181: Vitou V, Gély-Nargeot MC, Jeandel C, Bayard S. The influence of Alzheimer's
disease stigma on pain assessment in older persons. Dementia (London). 2022 Aug
17:14713012221117907. doi: 10.1177/14713012221117907. Epub ahead of print. PMID:
35976758.

182: Majumder P, Edmison D, Rodger C, Patel S, Reid E, Gowrishankar S. AP-4
regulates neuronal lysosome composition, function, and transport via regulating
export of critical lysosome receptor proteins at the trans-Golgi network. Mol
Biol Cell. 2022 Oct 1;33(12):ar102. doi: 10.1091/mbc.E21-09-0473. Epub 2022 Aug
17. PMID: 35976706.

183: Rubin R. Much Anticipated Alzheimer Disease Prevention Trial Finds No
Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other
Approaches. JAMA. 2022 Sep 13;328(10):907-910. doi: 10.1001/jama.2022.11490.
PMID: 35976676.

184: Huffels CFM, Middeldorp J, Hol EM. Aß Pathology and Neuron-Glia
Interactions: A Synaptocentric View. Neurochem Res. 2022 Aug 17. doi:
10.1007/s11064-022-03699-6. Epub ahead of print. PMID: 35976488.

185: Briel N, Ruf VC, Pratsch K, Roeber S, Widmann J, Mielke J, Dorostkar MM,
Windl O, Arzberger T, Herms J, Struebing FL. Single-nucleus chromatin
accessibility profiling highlights distinct astrocyte signatures in progressive
supranuclear palsy and corticobasal degeneration. Acta Neuropathol. 2022
Oct;144(4):615-635. doi: 10.1007/s00401-022-02483-8. Epub 2022 Aug 17. PMID:
35976433; PMCID: PMC9468099.

186: Studart-Neto A, Coutinho AM. From clinical phenotype to proteinopathy:
molecular neuroimaging in neurodegenerative dementias. Arq Neuropsiquiatr. 2022
May;80(5 Suppl 1):24-35. doi: 10.1590/0004-282X-ANP-2022-S138. PMID: 35976328.

187: Brucki SMD, César-Freitas KG, Spera RR, Borges CR, Smid J. Are we ready to
use anti-amyloid therapy in Alzheimer's disease? Arq Neuropsiquiatr. 2022
May;80(5 Suppl 1):15-23. doi: 10.1590/0004-282X-ANP-2022-S117. PMID: 35976307.

188: Federico S, Moro S. Promising Targets and Strategies to Control
Neuroinflammation (Part II). Curr Med Chem. 2022 Aug 6;29(28):4779. doi:
10.2174/092986732928220629152149. PMID: 35975903.

189: Wang Y, Wang D, Lv H, Dong Q, Li J, Geng W, Wang J, Liu F, Jia L, Wang Y.
Modulation of the Gut Microbiota and Glycometabolism by a Probiotic to Alleviate
Amyloid Accumulation and Cognitive Impairments in AD Rats. Mol Nutr Food Res.
2022 Aug 17:e2200265. doi: 10.1002/mnfr.202200265. Epub ahead of print. PMID:
35975737.

190: Nielsen TL, Kruse NB, Haahr A, Hjelle EG, Bragstad LK, Palmar-Santos A,
Navarta-Sánchez MV, Pedraz-Marcos A, Pires SB, Roberts HC, Portillo MC.
Exploring health and social services in Denmark, Norway, Spain and the United
Kingdom for the development of Parkinson's care pathways. A document analysis.
Health Soc Care Community. 2022 Aug 17. doi: 10.1111/hsc.13970. Epub ahead of
print. PMID: 35975602.

191: Uscamayta Ayvar M, Garrafa RS, Escobar JI, Gallo C, Vaisberg A, Poletti G,
de Erausquin GA. Non-affective psychosis in traditional Andean culture.
Transcult Psychiatry. 2022 Aug 17:13634615221099795. doi:
10.1177/13634615221099795. Epub ahead of print. PMID: 35975582.

192: Ma Y, Sun J, Che G, Cheng H. Systematic Infection of Chlamydia Pneumoniae.
Clin Lab. 2022 Aug 1;68(8). doi: 10.7754/Clin.Lab.2021.210908. PMID: 35975489.

193: Zhong X, Chen B, Hou L, Wang Q, Liu M, Yang M, Zhang M, Zhou H, Wu Z, Zhang
S, Lin G, Ning Y. Shared and specific dynamics of brain activity and
connectivity in amnestic and nonamnestic mild cognitive impairment. CNS Neurosci
Ther. 2022 Aug 17. doi: 10.1111/cns.13937. Epub ahead of print. PMID: 35975454.

194: Cai S, Kim MW, Chen P. Endoplasmic reticulum stress and mitochondrial
dysfunctions in metal-induced neurological pathology. J Neurobiol Physiol.
2022;4(1):4-8. PMID: 35975097; PMCID: PMC9377670.

195: Springer SD, Wiesman AI, May PE, Schantell M, Johnson HJ, Willett MP,
Castelblanco CA, Eastman JA, Christopher-Hayes NJ, Wolfson SL, Johnson CM,
Murman DL, Wilson TW. Altered visual entrainment in patients with Alzheimer's
disease: magnetoencephalography evidence. Brain Commun. 2022 Aug 1;4(4):fcac198.
doi: 10.1093/braincomms/fcac198. PMID: 35974799; PMCID: PMC9374481.

196: Chang HW, Ma HI, Wu YS, Lee MC, Chung-Yueh Yuan E, Huang SJ, Cheng YS, Wu
MH, Tu LH, Chan JCC. Site specific NMR characterization of abeta-40 oligomers
cross seeded by abeta-42 oligomers. Chem Sci. 2022 Jun 22;13(29):8526-8535. doi:
10.1039/d2sc01555b. PMID: 35974768; PMCID: PMC9337746.

197: Federico S, Moro S. Promising Targets and Strategies to Control
Neuroinflammation (Part I). Curr Med Chem. 2022;29(27):4630. doi:
10.2174/092986732927220629150904. PMID: 35974678.

198: Vasylenko O, Gorecka MM, Waterloo K, Rodríguez-Aranda C. Reduction in
manual asymmetry and decline in fine manual dexterity in right-handed older
adults with mild cognitive impairment. Laterality. 2022 Aug 16:1-24. doi:
10.1080/1357650X.2022.2111437. Epub ahead of print. PMID: 35974663.

199: Rohrer J, Ryan B, Ahmed R. <i>MAPT-</i>Related Frontotemporal Dementia.
2000 Nov 7 [updated 2022 Aug 18]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA,
Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews<sup>®</sup>
[Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. PMID:
20301678.

200: Lam S, Hérard AS, Boluda S, Petit F, Eddarkaoui S, Cambon K; Brainbank
Neuro-CEB Neuropathology Network, Picq JL, Buée L, Duyckaerts C, Haïk S, Dhenain
M. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta
plaque-bearing mice. Acta Neuropathol Commun. 2022 Aug 16;10(1):112. doi:
10.1186/s40478-022-01410-y. PMID: 35974399; PMCID: PMC9380345.